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Abstract

Protein signaling is the key method by which cells r ecognize a
stimulus from their environment and convert it into a response.
Signaling occurs in many forms: hormones, growth factors,
and even proteins may act as signals from the environment.
The response to their detection must be carried from the cell
surface, where the signal is detected, to the nucleus, where
the cell alters its DNA expression. This study analyzes one
component in the signaling pathway of Spleen Tyrosine
Kinase (Syk). The Syk protein receives a signal from B-cell
receptors and amplifies it, resulting in an adaptive immune
response and the production of antibodies for targeting foreign
molecules. S
 trikingly, constant amplification of the Syk
signal can transform B-cells into a cancerous phenotype and
has been associated with cancers of the lymphatic system.
Syk has also been implicated in autoimmune diseases such
as rheumatoid a rthritis. This study uses nuclear magnetic
resonance spectroscopy to determine the structure of a segment
from the Syk protein bound to Vav1, a downstream signaling
protein that has been implicated in various cancers. The
preliminary result will be refined using a molecular dynamics
simulation to obtain the most energetically stable conformation
of the protein-ligand interaction. The terminal results of this
experiment will reveal the structural details of the Syk-Vav1
interaction, which may describe a possible therapeutic target in
the treatment of proliferative B-cell disorders, as well as some
types of cancer. Using this information, one or more drugs
may be synthesized to block the interaction in cancerous cells,
providing a therapeutic avenue to treat the disease.
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Introduction
Purpose of study
Many serious human disorders are caused by errors
in cell signaling pathways. Just as a short circuit can
induce dysfunction in an electrical system, broken
cellular c omponents can cause improper behavior in a
cell, which may damage the host organism. The most
well-known example of such a disorder is cancer. Caused
by a plethora of mutations in the large and complex cell
signaling network, cancer is the uncontrolled growth and
reproduction of a cell with a broken signaling pathway.
The results of this disease can devastate the patient,
underscoring the urgent need for continuing cancer research.
This study models the interaction of proteins in one signaling junction of B-cells. Both proteins modeled have been
implicated in various cancers when mutated, suggesting
that a physical structure representing their bound state
could shed light on a possible method of cancer treatment.
This experiment models the interaction between Spleen
Tyrosine Kinase (Syk) and Vav1. Syk is a non-receptor
protein tyrosine kinase (Sada, Takano, Yanagi, &
Yamamura, 2001); that is, it functions to add a phosphate
group to a tyrosine amino acid of another protein. Syk
is activated upon stimulation of the B-cell receptor.
Two major signaling outcomes are Ca2+ release within
the cell and the activation of the MAP Kinase cascade,
both leading to changes in DNA expression and cell
morphology (Marx, 1993).
Vav1 is a multifunctional hub protein. It has several
components, including a GEF domain for protein signal
activation, SRC Homology domains for mediating

i nteractions with other proteins, and several other
domains (Katzav, 2005). Vav1 interacts with Syk via its
SH2 (SRC Homology 2) domain. This domain has high
affinity for phosphorylated tyrosine residues. Because
tyrosine kinases often autophosphorylate (Murray,
Padrique, Pinko, & McTigue, 2001), kinase-substrate
binding via SH2-phosphotyrosine affinity is conserved
across a spectrum of cellular tyrosine kinases. Despite
the fact that structures of SH2 domains are known, each
such domain is specific to one or a few target proteins,
requiring a model to be constructed de novo (Birge &
Hanafusa, 1993). This study may therefore provide useful
data about the interaction of Syk and Vav1 through Vav1’s
SH2 domain, which may serve as a basis for rational drug
design targeting either of the two proteins studied.

The role of Syk kinase in cell signaling
Syk is a non-receptor protein kinase whose activity is
essential to the clonal expansion of B-cells (Autoimmune
Diseases, 2010). A crucial immune component, B-cells
are responsible for producing antibodies. Activation of
the B-cell receptor by an antigen initiates a signaling
sequence in which Syk binds to the ITAM protein, which
induces Syk autophosphorylation. Many downstream
proteins in the Syk signal are directly implicated in
cellular proliferation, such as Cbl, PLC-γ, PI 3-K, MAP
Kinase, and Vav1. It is therefore unsurprising that Syk
regulation is essential for normal cell development and
transformation into cancer.
Although most effector proteins in the Syk pathway
induce cellular proliferation, they differ in their modes
of action. While inhibition of Syk greatly impedes B-cell
3d picture of the syk-vav1 protein complex
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 evelopment, disruption of a Syk-substrate interaction
d
could have a pathway-specific result. Therefore, the
structural determination of a Syk-substrate interface could
provide the necessary information for the synthesis of a
drug that would normalize cell function. The development
of such drugs could aid in efforts to combat autoimmune
diseases such as rheumatoid arthritis.

The polyfunctional protooncogene product Vav1
Vav1 is a hub protein containing multiple domains, each
with a purpose in signaling. The N-terminal region
contains a CH domain that is used to bind to the cellular
scaffold in other proteins. In Vav1, however, it may regulate
Ca2+ release (Billadeau & Turner, 2002). The Vav1 DH
domain is the active site; its GEF activity exchanges GDP
for GTP in a class of proteins known as GTPases, thereby
activating them. Neighboring regions in the Vav1 protein
serve to bind GEF targets to facilitate their activation. The
remaining region contains a set of conserved sequences
called SH (SRC Homology) domains, which bind specific
protein regions. Vav1 contains two SH3 domains, which
bind to proline-rich motifs. Vav1 binds to Syk via the SH2
domain residing between the two SH3 regions.
Vav1 has been implicated in cancers via incorrect
localization, overexpression, and overactivation
(Billadeau, 2010). Research has shown that expression
of Vav1 in pancreatic cells results in tumorigenesis in
this organ (Fernandez-Zapico, et al., 2005). Similarly,
expression of Vav1 in breast tissue may contribute to
t umor formation (Lin & Van Golen, 2004). Vav1 is
activated through phosphorylation by Syk (Deckert,
1996). Structural study of the Syk-Vav1 complex may lead
to rationally designed inhibitors functioning to prevent
Vav1 activation in cells overexpressing or constitutively
activating this protein.

The role of NMR spectroscopy in
structural studies
NMR, or Nuclear Magnetic Resonance spectroscopy, uses
the magnetic properties of some atomic nuclei (mainly 1H,
19
F, 13C, 15N) to provide information about their throughbond or through-space connectivity (NMR Spectroscopy,
n.d.). The nuclei involved in these interactions are
characterized by their nonzero spin quantum number and
associated nuclear magnetic moment. In the p resence of
an external magnetic field, the ensemble of these nuclei
within the sample generates a net magnetic moment,
also called magnetization, which aligns parallel to the
applied field. This magnetization can be pictured as
a vector whose length is governed by the Boltzmann
distribution law applied to nuclear magnetic moments. A
short e lectromagnetic pulse at radiofrequency (RF pulse)
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 erpendicular to the main magnetic field deflects the
p
magnetization v ector from its original direction, causing
it to rotate. Information about the structure is gathered
from the d iffering precession speeds of the magnetization
vectors belonging to the different types of nuclei, or to
the same nucleus but in different chemical environments.
A Fourier transform of the signal induced in the receiver
coil of the spectrometer by the magnetization allows the
identification of a characteristic precession frequency for
each nucleus in the protein.
The utility of the nuclear resonance for chemical and
biological applications results from the microenvironment
of the atom. As a magnetic field is imposed upon the
electrons surrounding the nucleus, they redistribute and
generate their own field in the opposite direction of the
applied field. This electron field lowers the strength of the
total magnetic field acting on the nucleus. This process,
known as shielding, causes distinct resonant frequencies
of most atoms in a molecule. Increased shielding decreases
the necessary energy to flip the nuclear orientation in the
magnetic field, which lowers the resonance frequency of
the nucleus. A variety of NMR experiments have been
devised to aid in assigning each resonance frequency to a
specific nucleus in a protein. Furthermore, expected resonance frequencies for each atom across all amino acids
that make up proteins are available in an online database.
Determining the three-dimensional structure of a large
protein molecule (>1,000 atoms) is challenging. The
crucial piece of information that NMR is able to resolve is
the Nuclear Overhauser Effect (NOE), which is a change
in signal intensity caused by the magnetic interaction
of two closely spaced nuclei (Gemmecker, 1999). The
NOE signal depends on distance between two protons (r),
specifically on r -6 , and is a through-space—as opposed to
a through-bond—interaction (Wüthrich, 2002). Because
the effect occurs at the resonance frequency of both interacting nuclei, it can be correlated to known signals. These
data enable the spectroscopist to obtain distance restraints
between many pairs of protons within the protein.
While the distance restraints severely limit the number
of possible conformations of the polypeptide chain,
giving it a general shape, the exact conformation of the
protein cannot be obtained from NMR data alone. Rather,
simulations utilizing molecular mechanics calculate
possible conformations consistent with the distance
restraint data and energy considerations. Generally, the
correct protein structure has the lowest free energy and
is therefore in the most thermodynamically stable state.
However, other methods have been devised that c ombine
energy considerations with other relevant factors to
predict the most likely structure (Güntert, 2004).

Materials and methods

Chemical shift and dihedral restraint assignment

Protein isolation

Assignment of the chemical shifts in the spectrum
was performed using the program Sparky (Goddard &
Kneller, 2008). Analysis and assignment of the Vav1
SH2 15N-HSQC was performed by Dr. Chih-Hong
Chen. Subsequent chemical shifts were assigned using
the 15N-HSQC data, as well as standard chemical shift
values obtained from the Biological Magnetic Resonance
Bank at the University of Wisconsin (Full Chemical
Shift S
 tatistics, 2011). Torsion angle restraints for the
amino acid backbone were predicted by the program
TALOS (Shen, Delaglio, Cornilescu, & Bax, 2010) and
incorporated into the structure calculation.

Recombinant E. coli expressing GST-tagged Vav1 SH2
were cultured in vitro. The bacteria were then lysed using
a French pressure cell press (French press) and centrifuged
to separate nuclear and cytoplasmic components. The
resulting homogenate was filtered and purified using
an ÄKTA (GE Healthcare) HPLC platform equipped
with a GST-affinity column. GST was cleaved during
a second elution through a His-affinity column after
addition of TEV protease. Protein levels during elution
were measured using the built-in optical spectrometry
capability of the ÄKTA platform and were then confirmed
using electrophoresis. Purified protein was transported on
ice for experimentation.

NMR experimentation
A 13-residue peptide homologous in sequence to the
SH2-interacting Syk loop was titrated with the purified
SH2 domain. Following titration, several protein, c arbon,
and nitrogen NMR experiments were performed for
chemical shift assignment. Three NOESY spectra were
also recorded for NOE assignment. All experiments were
performed on a Bruker Avance-III-800 spectrometer. A
full list of experiments performed can be found in Table 1.
Region
Backbone
Backbone
Backbone
Backbone
Backbone
Aliphatic Side Chain
Aliphatic Side Chain
Aliphatic Side Chain
Aliphatic Side Chain
Aliphatic Side Chain
Aromatic Side Chain
Aromatic Side Chain
Aromatic Side Chain
Peptide Backbone &
Side Chain
Peptide Backbone &
Side Chain
Intramolecular NOE
Intramolecular NOE
Intermolecular NOE

Experiment Name
N-HSQC
CBCA(CO)NH
HNCACB
HNCA
HN(CO)CA
C(CO)NH-TOCSY
H(CCO)NH-TOCSY
TOCSY-HSQC
H(C)CH-TOCSY
(H)CCH-TOCSY
HBCBCGCDHD
HBCBCGCDCEHE
13
C-HSQC
2D Double-Filtered TOCSY
2D Double-Filtered NOESY
N/13C-NOESY-HSQC
13
C-NOESY-HSQC
3D (13C/15N)-filtered 13C-edited
NOESY-HSQC
15

NOE assignment and structure calculation
Both NOE peak assignment and protein structure
calculation were completed by the program CYANA
(Güntert, 2004). CYANA is a computational package that
constructs protein structures based on the minimization
of a target function, which factors in the target structure’s
conformity to distance and dihedral restraints. The
CYANA modeling function is based on simulated
annealing; only torsion angles between atoms are treated
as degrees of freedom in the calculation, leading to
reduced computational requirements. CYANA also has
a built-in NOE assignment routine that dynamically
communicates with the structure calculation package,
allowing for on-the-fly selection of peaks based on their
conformity to an “NOE network” established from trends
in the peak data.
During initial protein-peptide simulations, no binding was
evident in the structure produced by CYANA. CYANA
either discarded peaks from the filtered intermolecular
NOESY spectrum or assigned the peaks to protein, rather
than to peptide atoms. To combat this, Piraner NMR
Suite, an NOE peak labeling p rogram, was developed in
C+. This program performed NOE a ssignment based on
chemical shift similarity or structure-guided constraints
derived from a template structure. Furthermore, this
program allowed rapid analysis of the output peak lists to
determine the source of all assignments. It was discovered
that out of the 327 peaks identified in the filtered NOESY
spectrum, 232 could be completely assigned using shifts
contained only in the protein chemical shift list, while
only 24 could be assigned using the peptide CS list. This
poor result can be attributed to a leaky filter and poor
sensitivity of the filtered TOCSY experiments, which lead
to suboptimal peptide chemical shift coverage.

Table 1. Experiments performed on Bruker Avance-III-800
spectrometer. (Courtesy of Dr. Chih-Hong Chen.)
3d picture of the syk-vav1 protein complex
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NOE and structure refinement
Intermolecular NOEs were picked manually out of the list
provided by Piraner NMR Suite based on their conformity
to the projected Syk binding site of the SH2 domain, as
projected by a previous component of this study. These
peaks were incorporated into CYANA calculations using
the KEEP subroutine. The molecular dynamics simulator
XPLOR-NIH (Schwieters, 2003) refined the CYANA
structure to obtain the lowest energy conformation.

Results and discussion
Sparky data
Chemical shift assignment was initialized from the
pre-assigned 2D 15N-HSQC (see Figure 1). This spectrum
contained the chemical shifts of the amide nitrogen and
protons for all residues except 1-3, 15, 38-45 (flexible
loop), 57, 60-61, and 104. The chemical shifts of other
atoms were assigned using the N-HSQC data. The
chemical shift coverage of the protein as assigned in

Sparky was nearly complete; according to the CYANA
initialization report, 90.6% of the atoms in the protein
were matched to a chemical shift.
Chemical shift determination of the peptide was far less
successful. A combination of a leaky filter and poor
sensitivity rendered chemical shift assignment difficult. In
total, 76.8% of the peptide chemicals shifts were assigned.
This poor coverage likely contributed to the lack of NOE
restraints generated between the peptide and the protein.

CYANA calculations
To create a consensus protein structure, two CYANA
calculations were performed. In the first, CYANA was
allowed to select and drop NOE peaks at the discretion
of its algorithm. In the second, the KEEP subroutine was
used to preserve the 24 protein-peptide NOE assignments
generated by Piraner NMR Suite. The CYANA results
show a precise protein structure being determined, with
a heavy atom RMSD near one Å. Table 2 displays the
calculation statistics for both CYANA runs.

Figure 1. Chemical shift assignment initialized from the pre-assigned 2D 15N-HSQC.
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Parameter
Extent of assignments
Number of distance constraints

Manually Assigned
Intermolecular NOEs
88.5% (of protein + peptide)
1499

Automatically Assigned
Intermolecular NOEs
88.5% (of protein + peptide)
1681

Number of dihedral restraints
Distance constraint violations
Dihedral restraint violations
Average backbone RMSD to mean
Average heavy atom RMSD to mean

1161
125
58
1.35 +/- 0.26 Å
1.88 +/- 0.25 Å

1161
3
0
0.9 +/- 0.23 Å
1.41 +/- 1.21 Å

Table 2. Results of CYANA calculations.

The first CYANA calculation resulted in a low RMSD
and few distance or dihedral restraint violations. However,
the resulting structure did not show any association
between the protein and the peptide. Examination of the
NOE peaks assigned by CYANA revealed that none of the
24 intermolecular peaks assigned by Piraner NMR Suite
had been similarly labeled by the CYANA NOEassign
function. This may be attributed to the small amount
of such peaks. The CYANA NOEassign routine takes
“network anchoring” into account. A lack of similar peaks
would induce the program to treat the intermolecular
peaks as noise and discard them. The second calculation
has many restraint violations in every structure. However,
the resulting structure may show the peptide associating
with the protein. The structural violations are due to
erroneous peak assignment. Because Piraner NMR Suite
cannot check the validity of assignment for a structure
without a template, it outputs results based solely on
shift matching of the NOE peaks to the c hemical shift
library. Furthermore, because some peaks may correlate

Figure 2. Structure ensemble for
the SH2 domain.

to the chemical shift of more than one atom, the p rogram
outputs all possible chemical shift assignments as
duplicate peaks. The output peak list contains some
impossible combinations, such as duplicate peaks in
which one copy relates an interaction between a peptide
atom and an N-terminal protein region, while the other
contains the same peptide atom and a protein C-terminal
atom. These discrepancies must be analyzed based on
previous work with Vav1 SH2 to remove i mpossible
distance restraints, thereby removing the cause for the
multitude of restraint violations.

Protein structure output
CYANA generates an ensemble of the 20 structures
best conforming to the NMR data. Figure 2 shows the
structure ensemble for the SH2 domain only. The location
of the peptide is not visualized. Throughout the structure
ensemble, some conserved components may be clearly
seen, including the central β sheet (B) flanked by two α
helices (A1 & A2) typical of SH2 domains. Other regions

Figure 3. Lack of binding between
the protein and the peptide in the
SH2 domain.

Figure 4. The SH2 domain possibly
bound to the Syk peptide, with restraints
retained between the protein and peptide.

3d picture of the syk-vav1 protein complex
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of interest include the small, transient flanking β sheet
(C) and another α helix (D). This overall SH2 structure
coincides well with that of SH2-pYpY obtained in an
earlier part of this study by Dr. Chen.

the calculations, a full 20 structure ensemble is difficult
to visualize. Therefore, only the first structures, which
correspond to the lowest CYANA target functions, are
visualized in each case.

Figures 3 and 4 display the same SH2 domain bound to
the Syk peptide. Unlike in the previous study conducted
by Dr. Chen, which modeled the interaction between
Vav1 SH2 and a doubly phosphorylated pYpY peptide,
this model studies the binding of a singly phosphorylated
YpY chain. The phosphorylation sites are separated by
three amino acids, with tyrosines 5 and 9 of the peptide
phosphorylated in the pYpY structure, and only Y9
phosphorylated in the YpY-bound structure examined in
the study. Due to the variability in peptide placement in

Figure 3 clearly displays a lack of binding between the
protein and the peptide. Note that due to the method of
linking the peptide to the protein used in the CYANA
calculation, the peptide resembles an extension of the
SH2 domain. The lack of NOE restraints in this structure
combined with a Van der Waals repulsion between
the protein and peptide lead to a minimization of the
CYANA target function when the peptide is placed far
from the protein. Figure 4, in which restraints between
the protein and peptide are retained, may show some
interaction between the protein and peptide. However,
the large number of distance and angle violations in this
structure renders it only a starting point for determination
of the actual s tructure. Manual resolution of the intermolecular distance restraints will enable a true structure
to be d etermined. Figures 5 and 6 display the Van der
Waals surface of main chain atoms of the protein and
peptide with automatic assignment (Figure 5) and manual
assignment (Figure 6).

Further experimentation
Clearly, correct determination of the protein-peptide
structure requires manual assignment of the
intermolecular NOE peaks. The current contradictory
information leads to far more torsion and distance
restraint violations than can be tolerated for a true protein
structure. Resolution of the contradictory distance restraints
will lead to the determination of the correct structure
of the Vav1-Syk interaction. Refinement of the CYANA
structure will be performed with XPLOR-NIH. This
program will use molecular dynamics computations to
minimize the energy of the structure created by CYANA.
Though no drastic alterations are expected, the calculation may slightly modify some topological features of the
protein, which are important for interaction with Syk and
possibly the rest of the Syk-complexed “signalosome.”

Conclusion

Figure 5 and Figure 6. Contact surface of the protein
and peptide.
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The NMR structure determination of Vav1 SH2 bound
to the YpY Syk peptide will provide information about
SH2 binding behavior in this complex. This information
could be used to design an inhibitor that would compete
with Syk for Vav1 binding, thereby altering the signaling
outcome in B-cells. The implication of constitutively

a ctive Syk and Vav1 in cancer and autoimmune
disorders s uggests that such alteration of their activity
could represent a possible avenue in the treatment of
such diseases. Once the correct SH2-YpY structure is
determined, the difference between it and the pYpY model
may be used to assess the influence of phosphorylation on
the structure, possibly providing information leading to
the development of drugs that counteract excess signaling
by these two proteins.
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